Obviously due to the rapidly changing environment surrounding the pandemic this has setback much of our learning & reading. I will do my best to update you again soon.
There has been some exciting news recently with EpiVax announcing that it has made great strides in developing precision cancer immunotherapies. You can check out one the 'Freshest' articles on them here: https://www.prnewswire.com/news-releases/epivax-oncology-completes-a-1-2m-bridge-financing-300665275.html Amaz